基因智能控股

最新新闻

• 评级变动
  Piper Sandler Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $130
  \u5e02\u573a\u8d44\u8baf · 2026/4/21
• 评级变动
  Wells Fargo Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $155
  \u5e02\u573a\u8d44\u8baf · 2026/2/25
• 评级变动
  Piper Sandler Maintains GeneDx Holdings(WGS.US) With Buy Rating, Cuts Target Price to $63
  \u5e02\u573a\u8d44\u8baf · 2026/6/23
• 评级变动
  A Quick Look at Today's Ratings for GeneDx Holdings(WGS.US), With a Forecast Between $130 to $170
  \u5e02\u573a\u8d44\u8baf · 2026/2/24
• 评级变动
  Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Announces Target Price $85
  \u5e02\u573a\u8d44\u8baf · 2026/5/5
• 评级变动
  Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Announces Target Price $153
  \u5e02\u573a\u8d44\u8baf · 2026/3/12
• Wells Fargo Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $75
  \u5e02\u573a\u8d44\u8baf · 2026/7/30
• 评级变动
  Jefferies Maintains GeneDx Holdings(WGS.US) With Buy Rating, Cuts Target Price to $100
  \u5e02\u573a\u8d44\u8baf · 2026/5/27
• 评级变动
  Guggenheim Maintains GeneDx Holdings(WGS.US) With Buy Rating, Cuts Target Price to $100
  \u5e02\u573a\u8d44\u8baf · 2026/3/30
• 评级变动
  CCORF Maintains GeneDx Holdings(WGS.US) With Buy Rating, Cuts Target Price to $100
  \u5e02\u573a\u8d44\u8baf · 2026/4/20
• 评级变动
  CCORF Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $170
  \u5e02\u573a\u8d44\u8baf · 2026/3/13
• A Quick Look at Today's Ratings for GeneDx Holdings(WGS.US), With a Forecast Between $75 to $103
  \u5e02\u573a\u8d44\u8baf · 2026/8/5
• 评级变动
  TD Cowen Maintains GeneDx Holdings(WGS.US) With Buy Rating, Cuts Target Price to $85
  \u5e02\u573a\u8d44\u8baf · 2026/7/16
• 评级变动
  A Quick Look at Today's Ratings for GeneDx Holdings(WGS.US), With a Forecast Between $70 to $130
  \u5e02\u573a\u8d44\u8baf · 2026/5/5
• BTIG Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $90
  \u5e02\u573a\u8d44\u8baf · 2026/7/23
• 评级变动
  Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/6/10
• 评级变动
  Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $85
  \u5e02\u573a\u8d44\u8baf · 2026/5/14
• 评级变动
  Guggenheim Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $74
  \u5e02\u573a\u8d44\u8baf · 2026/6/29
• Guggenheim Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $83
  \u5e02\u573a\u8d44\u8baf · 2026/10/1
• Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $103
  \u5e02\u573a\u8d44\u8baf · 2026/9/23

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。